Actually, accumulating evidence has demonstrated that probiotics, including B. lactis and L. plantarum, can down-regulate hyperactivated PI3K/AKT pathway in numerous diseases both in vivo and in vitro, such as colorectal cancer, gastric cancer and aging (Mohseni et al., 2021). The gene discussed is AKT1; the disease is colorectal cancer.